Trials / Terminated
TerminatedNCT00627913
Retrobulbar Injection of Anesthesia Versus Healon 5 in the Management of Intraoperative Floppy Iris Syndrome
Retrobulbar Injection of Anesthesia Versus Injection of Healon 5 Viscoelastic Into the Anterior Chamber in the Management of Intraoperative Floppy Iris Syndrome
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Penn State University · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
In this study, the investigators plan to compare the incidence and complications of intraoperative floppy iris syndrome (IFIS) during cataract surgery in patients taking tamsulosin (Flomax) and treated with retrobulbar injection of anesthesia, versus injection of Healon 5 viscoelastic into the anterior chamber.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Healon 5 injection | Healon 5 (2.3% Sodium hyaluronate) ophthalmic viscoelastic device will be injected into the anterior chamber as needed for pupillary dilation and adequate cataract extraction with intraocular lens placement. |
| PROCEDURE | Retrobulbar anesthetic injection | 3-4cc of anesthetic (1% lidocaine/0.75% bupivicaine) will be injected with a 25 gauge needle into the extraocular muscle cone prior to patient and microscope positioning. Cataract extraction with intraocular lens placement will then proceed in standard fashion. |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2010-11-11
- Completion
- 2010-11-11
- First posted
- 2008-03-04
- Last updated
- 2017-11-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00627913. Inclusion in this directory is not an endorsement.